Centro Cellex, Calle Natzaret, 115-117
Barcelona, 08035
Spain
Vall d'Hebron University Hospital - Breast Cancer Group
Trastuzumab; Pertuzumab; De-escalation; Pathologic complete response; FDG-PET/CT; HER2-positive; Early breast cancer